Trans-splicing of RNA in Endometrail Stroma and Other Tissues
子宫内膜基质和其他组织中 RNA 的反式剪接
基本信息
- 批准号:8246474
- 负责人:
- 金额:$ 32.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-06-04 至 2014-04-30
- 项目状态:已结题
- 来源:
- 关键词:AddressCell LineCell NucleusCellsChromosomal RearrangementDataDevelopmentEndometrialEndometrial Stromal CellEndometrial Stromal TumorsEndometriumGene FusionGene RearrangementGenesGenetic TranscriptionGoalsHealthHumanHybridsKnowledgeLaboratoriesMethodsNormal tissue morphologyOncogenicPhenotypePolycombProceduresProcessProteinsRNARNA PrecursorsResearchRoleSiteTestingTissuesTrans-Splicingbasechimeric geneendometrial stromafusion geneinsightmRNA Precursorneoplastictumor
项目摘要
DESCRIPTION (provided by applicant): The research proposed in this application is based on the recent discovery in the applicant's laboratory that a JAZF1-JJAZ1 gene fusion in human endometrial stromal tumors mimics the results of trans-splicing between pre-mRNAs for these two genes in normal endometrial stromal cells. Additional evidence suggests that in the normal endometrium trans-splicing between the pre- mRNAs is physiologically regulated, but in the tumors the gene fusion produces chimeric RNA in an abnormal, dysregulated manner. These data have led to the hypothesis that fusions of genes in other tumors may contribute to the neoplastic phenotype of those tumors in a similar fashion, through the sustained expression of chimeric RNAs normally generated by trans-splicing during specific intervals in cell and tissue development. The preliminary findings and the above hypothesis will be pursued through five specific aims. The first two of these aims (determination of the intranuclear localization of JAZF1 and JJAZ1 pre-mRNAs during the trans-splicing process and identification of an RNA Y-form intermediate that should be unique for trans-splicing) will add further proof for trans-splicing by addressing features of the mechanism for this process. These aims will also provide research procedures that will be useful in studying other examples of trans-splicing. The third aim (analysis of trans-splicing between JAZF1 and PHF1 pre-mRNAs) will investigate a likely second case of a neoplastic gene fusion mimicking trans-splicing in endometrial stromal cells. The fourth aim (analysis of chimeric RNA function in endometrial stromal cells) will address the role of trans-splicing in normal endometrial stroma, and the fifth aim (demonstration of trans-splicing in cells other those of endometrial stroma) will determine whether several, selected gene fusions associated with certain human tumors reflect trans-splicing in the normal tissue counterparts of those tumors. In aggregate, the research proposed in this application will broaden knowledge of RNA trans-splicing in normal tissues and provide new insights into how an important class of DNA rearrangements exerts oncogenic effects in human tumors. PUBLIC HEALTH RELEVANCE: The JAZF1-JJAZ1 gene fusion is commonly found in tumors arising in the certain cells of the human endometrium and expresses a hybrid RNA that is identical to one produced by trans-splicing between RNA precursors in normal endometrial stroma. The proposed research will investigate the mechanism trans-splicing, its function in the endometrium, the participation in this process of other genes within endometrial cells, and whether or not gene fusions in other kinds of tumors reflect trans-splicing between RNA precursors in normal tissues.
描述(由申请人提供):本申请中提出的研究基于申请人实验室最近的发现,即人子宫内膜基质肿瘤中的JAZF1-JJAZ1基因融合体模拟了正常子宫内膜基质细胞中这两个基因的前体mRNA之间的反式剪接结果。其他证据表明,在正常子宫内膜中,前体 mRNA 之间的反式剪接受到生理调节,但在肿瘤中,基因融合以异常、失调的方式产生嵌合 RNA。这些数据导致了这样的假设:其他肿瘤中的基因融合可能通过嵌合RNA的持续表达以类似的方式促成这些肿瘤的肿瘤表型,嵌合RNA通常是在细胞和组织发育的特定时间间隔内通过反式剪接产生的。初步发现和上述假设将通过五个具体目标来实现。其中前两个目标(确定反式剪接过程中 JAZF1 和 JJAZ1 前 mRNA 的核内定位,以及鉴定反式剪接中唯一的 RNA Y 型中间体)将通过解决该过程的机制特征来进一步证明反式剪接。这些目标还将提供有助于研究反式剪接的其他例子的研究程序。第三个目标(分析 JAZF1 和 PHF1 前 mRNA 之间的反式剪接)将研究可能的第二例子宫内膜基质细胞中模拟反式剪接的肿瘤基因融合。第四个目标(分析子宫内膜基质细胞中的嵌合RNA功能)将解决反式剪接在正常子宫内膜基质中的作用,第五个目标(演示子宫内膜基质细胞以外的细胞中的反式剪接)将确定与某些人类肿瘤相关的几个选定的基因融合是否反映了这些肿瘤的正常组织对应物中的反式剪接。总的来说,本申请中提出的研究将拓宽正常组织中 RNA 反式剪接的知识,并为一类重要的 DNA 重排如何在人类肿瘤中发挥致癌作用提供新的见解。公共健康相关性:JAZF1-JJAZ1 基因融合体常见于人类子宫内膜某些细胞产生的肿瘤中,并表达一种杂合 RNA,该杂合 RNA 与正常子宫内膜基质中 RNA 前体之间反式剪接产生的 RNA 相同。拟议的研究将调查反式剪接的机制、其在子宫内膜中的功能、子宫内膜细胞内其他基因参与这一过程的情况,以及其他类型肿瘤中的基因融合是否反映了正常组织中RNA前体之间的反式剪接。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeffrey Sklar其他文献
Jeffrey Sklar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeffrey Sklar', 18)}}的其他基金
Trans-splicing of RNA in Endometrail Stroma and Other Tissues
子宫内膜基质和其他组织中 RNA 的反式剪接
- 批准号:
8053292 - 财政年份:2009
- 资助金额:
$ 32.59万 - 项目类别:
Trans-splicing of RNA in Endometrail Stroma and Other Tissues
子宫内膜基质和其他组织中 RNA 的反式剪接
- 批准号:
8456184 - 财政年份:2009
- 资助金额:
$ 32.59万 - 项目类别:
Trans-splicing of RNA in Endometrail Stroma and Other Tissues
子宫内膜基质和其他组织中 RNA 的反式剪接
- 批准号:
7632824 - 财政年份:2009
- 资助金额:
$ 32.59万 - 项目类别:
Research Programs-Gene Regulation and Functional Genomics
研究项目-基因调控与功能基因组学
- 批准号:
7513245 - 财政年份:2007
- 资助金额:
$ 32.59万 - 项目类别:
THE JAZF1 AND 2 GENES IN UTERINE SARCOMAS
子宫肉瘤中的 JAZF1 和 2 基因
- 批准号:
6641992 - 财政年份:2000
- 资助金额:
$ 32.59万 - 项目类别:
THE JAZF1 AND 2 GENES IN UTERINE SARCOMAS
子宫肉瘤中的 JAZF1 和 2 基因
- 批准号:
6522595 - 财政年份:2000
- 资助金额:
$ 32.59万 - 项目类别:
THE JAZF1 AND 2 GENES IN UTERINE SARCOMAS
子宫肉瘤中的 JAZF1 和 2 基因
- 批准号:
6377835 - 财政年份:2000
- 资助金额:
$ 32.59万 - 项目类别:
相似海外基金
Establishment of a Mouse NK Cell Line for Analyzing Tumor Infiltration Processes and Developing a Preclinical Model for Cancer Immunotherapy.
建立小鼠 NK 细胞系,用于分析肿瘤浸润过程并开发癌症免疫治疗的临床前模型。
- 批准号:
23K06731 - 财政年份:2023
- 资助金额:
$ 32.59万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Proof of usefulness of PDX derived cell line
PDX 衍生细胞系的有用性证明
- 批准号:
23K06616 - 财政年份:2023
- 资助金额:
$ 32.59万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A novel producer cell line for more efficient manufacturing of viral vector systems
用于更有效地制造病毒载体系统的新型生产细胞系
- 批准号:
10597799 - 财政年份:2023
- 资助金额:
$ 32.59万 - 项目类别:
Genestorian: a web application to document and trace genetic modifications in model organism and cell line collections.
Genestorian:一个网络应用程序,用于记录和追踪模型生物和细胞系集合中的遗传修饰。
- 批准号:
EP/Y024591/1 - 财政年份:2023
- 资助金额:
$ 32.59万 - 项目类别:
Fellowship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10672364 - 财政年份:2022
- 资助金额:
$ 32.59万 - 项目类别:
Developing a stable cell line expressing recombinant sclerostin
开发表达重组硬化素的稳定细胞系
- 批准号:
10385037 - 财政年份:2022
- 资助金额:
$ 32.59万 - 项目类别:
Development of Natural Killer (NK) Cell Line-Derived Extracellular Vesicles as a New Treatment for Cancer
开发自然杀伤 (NK) 细胞系衍生的细胞外囊泡作为癌症的新治疗方法
- 批准号:
10383462 - 财政年份:2022
- 资助金额:
$ 32.59万 - 项目类别:
A cell culture management platform to improve biomedical reproducibility by combining cell line tracking, low-cost genetic analysis, and riskassessment
细胞培养管理平台,通过结合细胞系追踪、低成本遗传分析和风险评估来提高生物医学重现性
- 批准号:
10483063 - 财政年份:2022
- 资助金额:
$ 32.59万 - 项目类别:
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10546865 - 财政年份:2022
- 资助金额:
$ 32.59万 - 项目类别:
Modulating expression of candidate genes to improve lentiviral vector production in stable cell line
调节候选基因的表达以提高稳定细胞系中慢病毒载体的产量
- 批准号:
2752732 - 财政年份:2022
- 资助金额:
$ 32.59万 - 项目类别:
Studentship